NUCLEOSIDES AND NUCLEOSIDE analogs are used in the treatment of neoplasms, viral infections, and cardiac arrhythmias. These compounds are hydrophilic and are transported across lipid membrane barriers by specific transporter proteins. There are two main classes of nucleoside transporters, equilibrative and concentrative. Concentrative nucleoside transporters are Na ϩ dependent and are present in renal and intestinal epithelium and in liver (39) . On the basis of substrate selectivity, several types of concentrative nucleoside transporters have been characterized as purine selective (N1), pyrimidine selective (N2) (30, 38) , and broadly selective (N3, N4, and N5) (7, 10, 11) . Transporters exhibiting N1-and N2-type characteristics, termed sodium-dependent purine-selective nucleoside transporter (SPNT or CNT2) and concentrative nucleoside transporter 1 (CNT1), respectively, have been cloned from various mammalian species (human, rat, and pig) (8, 12, 28, 31, 40) .
Nucleoside transporters appear to play major roles in the kidney. Both equilibrative and concentrative nucleoside transport activities have been observed in renal epithelium, where they are hypothesized to act sequentially to mediate the transepithelial flux of nucleosides. Equilibrative transport mechanisms have been primarily observed in basolateral membrane vesicle preparations whereas concentrative mechanisms have been observed in apical membrane vesicles, suggesting that nucleosides are transported in a reabsorptive direction (9, 10, (16) (17) (18) (19) . This model of reabsorptive flux is further substantiated by renal clearance studies in humans demonstrating active reabsorption of nucleosides (15, 27) . In contrast, evidence of secretion of nucleoside analogs challenges such reabsorptive schemes but may be explained by interaction of these analogs with secretory transporters in the kidney (1, 25, 26) .
In addition to their role in transepithelial flux, nucleoside transporters are also thought to modify the adenosine signaling in the kidney. Adenosine acts via adenosine receptors (A 1 , A 2A , A 2B , and A 3 ) to modify kidney function and has been implicated in the metabolic regulation of glomerular filtration rate (GFR), renin release, erythropoietin production, adrenergic transmission, urine flow, and solute excretion. Receptor function has been localized to the renal tubule (42) . Termination of receptor activity, by decreasing the level of adenosine in the vicinity of these receptors, is thought to occur via two mechanisms: 1) enzymatic deamination of adenosine and subsequent transportermediated internalization of inosine and 2) transportermediated internalization of adenosine (9) . Recent studies describe A 1 -like receptor activity on the apical membrane and A 2 -like activity on the basolateral membrane (6, 33) . Localization of nucleoside transporters to the apical or basolateral membrane is important in understanding their role in modulating adenosine action in the kidney.
To clearly understand the role of nucleoside transporters in the kidney in mediating the transepithelial flux of nucleosides and nucleoside analogs, it is critical to localize the transporters to the apical or basolateral membrane within renal epithelial cells. Such studies are also important in understanding the interrelationships between nucleoside transporters and adenosine receptor subtypes and the role of transporters in modulating the effects of adenosine in the kidney. Localization of transporters by using Madin-Darby canine kidney (MDCK) cells, a polarized renal cell line, has mimicked in vivo localization in many transporter protein studies (3, 23, 24, 37) . In this study we tagged the cloned nucleoside transporters, SPNT and CNT1, with green fluorescent protein (GFP) and expressed the resultant fusion proteins in MDCK cells. Stable expression of SPNT-GFP and CNT1-GFP in MDCK cells provides a method of visualizing the transporters to conclusively determine localization. The transfected cells may also be used to study the functional characteristics of these transporters and for studies of intracellular sorting and regulation of expression of SPNT and CNT1 nucleoside transporters.
MATERIALS AND METHODS

Materials.
Cell culture media and supplements were purchased from the University of California, San Francisco (UCSF) Cell Culture Facility (San Francisco, CA). G418 and blasticidin were purchased from Calbiochem (La Jolla, CA). Clontech (Palo Alto, Ca) provided eGFP-C1, and pcDNA3 and pcDNA6/V5-His/lacZ were purchased from Invitrogen (Carlsbad, CA). The pADtet7 vector and tet-off MDCK were a generous gift from Dr. Yoram Altschuler (UCSF) but are also available from Clontech (2). The EMBL MDCK II strain was a kind gift from Dr. Karl Matlin. Texas-red-conjugated phalloidin was purchased from Molecular Probes (Eugene, OR). Vectashield was supplied by Vector Laboratories (Burlingame, CA). Transwell polycarbonate cell culture filters and polycarbonate cell culture plates were purchased from Corning Costar (Corning, NY). Bradford reagent was supplied by Bio-Rad (Hercules, CA), and Pierce (Rockford, IL) provided albumin standard. Radiolabeled uridine, inosine, and thymidine were purchased from Moravek Biochemicals (Brea, CA). All other chemicals were purchased from Sigma (St. Louis, MO).
Plasmid construction. Rat SPNT and CNT1 were subcloned into the pcDNA3 vector by adding an EcoRV site to the 5Ј-end and a NotI site to the 3Ј-end using PCR. Both rat SPNT and CNT1 were subcloned into eGFP-C1 by adding a BglII site to the 5Ј-end and a SalI site to the 3Ј-end using the same method. SPNT-GFP was isolated from eGFP-C1 by adding an EcoRI site upstream to GFP and a XbaI site on the 3Ј-end of SPNT and was subcloned into the pADtet7 expression vector. All sequences were confirmed by automated sequence analysis at the Biomolecular Resource Center (UCSF).
Cell culture. All cells were maintained in MEM Eagle's with Earle's balanced salt solution (BSS) supplemented with 5% heat inactivated FBS, 100 U/ml penicillin, and 100 g/ml streptomycin in 5% CO 2-95% air. Cells were transfected with pcDNA3-CNT1, pcDNA3-SPNT, eGFP-C1-CNT1, pADtet7-SPNT, or empty vector by the calcium phosphate method as previously described (4). pADtet7-SPNT was cotransfected with pcDNA6-V5-His-lacZ at a ratio of 100:1 to confer resistance to blasticidin. pcDNA3-CNT1 and pcDNA3-SPNT were cotransfected with eGFP-C1 at the same ratio so that positive clones could be selected by fluorescence. Three days after transfection, stable clones were selected in media containing both 10 g/ml blasticidin and 20 ng/ml doxycycline (for the pADtet7-SPNT vector) or 0.7 mg/ml G418. After 10-14 days, individual stable clones were isolated and positive clones were further selected by immunocytochemistry and by [ 3 H] uridine uptake.
Uptake measurements. Unpolarized cells were seeded at 5 ϫ 10 4 cells/well in 24-well Costar polycarbonate plates and allowed to reach confluence over 3-4 days. Uptake measurements were made as previously described (35) . Cells were washed at room temperature in either Na ϩ (128 mM NaCl, 4.73 mM KCl, 1.25 mM CaCl2, 1.25 mM MgSO4, 5 mM HEPES-Tris, pH 7.4) or Na ϩ -free buffer in which choline chloride is substituted for NaCl. Buffer was aspirated, and cells were incubated in 10 M nucleoside (0.1 M radiolabeled nucleoside and 10 M unlabeled nucleoside) for a specific time (1-2 min unless otherwise noted). All uptakes were carried out in the presence of 10 M nitrobenzothioinosine (NBMPR) and in either the presence or the absence of Na ϩ . Uptake was stopped by aspiration of reaction mix and three washes in ice-cold Na ϩ -free buffer. Cells were solublized in 1 M NaOH for 2 h, neutralized with 1 M HCl, and counted on a Beckman scintillation counter. All studies were performed in triplicate. Data are reported as means Ϯ SD. All assays are repeated with empty vector or untransfected controls. In all cases, empty vector controls mirrored untransfected controls and are not reported. For all studies, two to three wells per plate were solublized and assayed for protein content by using the Bradford method (35) .
Inhibition studies. Inhibition assays were carried out for 1-4 min in triplicate. Briefly, Localization uptake studies. To determine the uptake of nucleosides across the apical or basolateral membrane, the following procedure was used. Individual stable clones were polarized by growth on Transwell filters at a confluent density for 7 days with regular media changes. Before the experiment, each filter was washed on both the apical and basolateral sides with either Na ϩ or Na ϩ -free buffer. In some cases, transepithelial electrical resistance (TEER) values were taken before uptake by using a Millicell-ERS (Millipore, Bedford, MA) equlibrated in Na ϩ buffer. Radiolabeled nucleoside at the same concentrations as stated above was added to either the apical or basolateral side, and nucleoside-free buffer was added to the opposite side. NBMPR (10 M) was added to both sides. Cells were incubated for 1-2 min. Radiolabeled nucleoside was aspirated, and filters were washed three times with ice-cold Na ϩ -free buffer. Filters were airdried, removed from plastic support, and counted on a Beckman scintillation counter. Two filters from each plate were solublized as described above and assayed for protein content.
Confocal microscopy. Samples grown on filters for 7 days as stated above were fixed with 4% paraformaldehyde, permeablized with 0.025% (wt/vol) saponin in phosphate buffered saline, stained with Texas-red conjugated phalloidin for visualization of actin, and mounted on slides in Vectashield mounting medium. Samples were analyzed using a BioRad MRC-1024 confocal microscope.
Transient transfection of LLC-PK1. LLC-PK1 cells were maintained in M-199 with Earle's BSS (UCSF Cell Culture Facility) supplemented with 3% heat-inactivated FBS, 100 U/ml penicillin, and 100 g/ml streptomycin in 5% CO2-95% air. Cells were grown on Transwell filters with a 0.4-m pore diameter for 72 h and then transfected in Optimem Reduced Serum Medium (UCSF Cell Culture Facility) using LipofectAMINE 2000 (GIBCO-BRL, Rockville, MD). Cells were then grown 24 or 48 h before being fixed and stained for confocal microscopy as described above.
Data analysis. All experiments were performed in triplicate on at least three separate occasions. For determination of statistical significance, Student's unpaired t-test was used and P Ͻ 0.05 was considered significant. For determination of intracellular uridine concentrations after uptake on polarized MDCK, the following values were used for all calculations: an intracellular volume (total cell volume minus nucleus and vesicles) of 897 fl/cell as determined by Butor and Davoust (5) and 500,000 cells/Transwell filter as determined by counting via hemocytometer.
RESULTS
Stable expression of SPNT-GFP and CNT1-GFP in epithelial cells.
To study the intracellular distribution of SPNT and CNT1, we constructed GFP fusion proteins. Using a PCR-based strategy, we tagged the NH 2 terminus of each transporter with a genetically stabi- lized form of the Aequorea victoria GFP to generate SPNT-GFP and CNT1-GFP. Each tagged transporter was stably expressed in MDCK cells (Fig. 1, A and B) . MDCK cells have low background concentrative nucleoside transport activity and form uniform, tight monolayers. The SPNT-GFP clone was capable of being expressed in a doxycycline-repressible fashion but for the purpose of these studies was expressed continuously in the same manner as were the other clones. In addition, we constructed stable transfections of wildtype SPNT and CNT1 and all empty vectors. Functionality of SPNT-GFP and CNT1-GFP was investigated to determine (1) whether the tagged transporters were functionally active and (2) whether the GFP tag kinetically altered the activity of the transporters. Na ϩ -dependent uptake of [ 3 H]uridine in cells expressing SPNT-GFP or CNT1-GFP was significantly increased over uptake in untransfected or empty vector-containing cells (data not shown). TEER values did not differ significantly between transfected and untransfected cells, indicating no difference in monolayer tightness. Time-dependent Na ϩ -stimulated uptake was linear at early times and plateaued at 10 min for both clones (data not shown). Subsequently, all activity assays were performed for 1-2 min unless otherwise noted. Na ϩ -dependent [ 3 H]uridine uptake by CNT1-and SPNT-transfected cells (both tagged and untagged) grown in Transwells was concentrative, with a final cellular uridine concentration ϳ10 times larger than the extracellular concentration.
We examined the substrate selectivity of the tagged transporters by observing the uptake of several radiolabeled endogenous nucleosides ( (Fig. 2) . No significant uptake was observed in untransfected cells or empty vector clones. These results are consistent with the expected substrate selectivity of SPNT and CNT1 and indicate that the GFP tag does not alter selectivity of these transporters. The IC 50 of uridine as an inhibitor of [ 3 H]uridine uptake was 3.97 Ϯ 0.86 M for SPNT-GFP and 5.51 Ϯ 1.45 M for untagged SPNT (Fig. 3A) . The IC 50 of uridine was 11.0 Ϯ 1.53 M for CNT1-GFP and 3.13 Ϯ 0.37 M for untagged CNT1 (Fig. 3B) . Although these values are statistically different, they represent only modest differences in transport activity.
Localization of SPNT-GFP and CNT1-GFP in polarized MDCK cells. SPNT-GFP and CNT1-GFP transfected MDCK cells were grown as a polarized monolayer on a permeable filter support and examined by confocal fluorescence microscopy. Vertical optical sections of both clones visualized at 488 nm show that SPNT-GFP and CNT1-GFP predominantly stain on the apical membrane (Fig. 1, A and B) . In the case of SPNT-GFP, those cells that are most highly transfected as determined by fluorescence levels show low levels of basolateral staining as well. In contrast, isolated GFP clones display a cytosolic pattern of expression, and untransfected cells do not display any GFP staining (Fig. 1, C and D) . These data indicate the GFP-tagged transporters predominantly localize to the apical membrane domain in MDCK cells.
To determine whether CNT1-GFP and SPNT-GFP showed a similar pattern of distribution in a proximal tubule cell line, we transiently transfected LLC-PK 1 cells and examined the proteins by confocal microscopy (Fig. 1, E and F) . In general, we observed a transfection efficiency of ϳ20% for both SPNT-GFP and CNT1-GFP. The patterns of distribution for both fusion proteins as well as GFP were identical to those observed in stably transfected MDCK. That is, GFP showed a cytoplasmic distribution, whereas both CNT1-GFP and SPNT-GFP were predominately localized to the apical membrane, with SPNT-GFP displaying a small amount of basolateral signal.
To further confirm apical localization, [ 3 H]uridine uptake from both apical and basolateral surfaces of polarized cells was examined. Na ϩ -dependent transport was seen primarily at the apical membrane in SPNT-GFP and CNT1-GFP cells (Fig. 4, A and B) as well as in SPNT and CNT1 cells (data not shown). Low levels of Na ϩ -dependent nucleoside transport at the basolateral membrane were observed for both tagged and untagged SPNT and CNT1. For CNT1-GFP and CNT1, Na ϩ -dependent basolateral uptake was 10 times lower than Na ϩ -dependent apical uptake. For SPNT-GFP and SPNT, Na ϩ -dependent basolateral uptake was 25% of its respective apical uptake. Basolateral activity may indicate low levels of basolateral localization. None of the empty vector clones exhibited uridine uptake that was significantly different from that in untransfected cells.
DISCUSSION
MDCK is the epithelial cell line most extensively used for studies of membrane trafficking pathways and has accurately predicted the in vivo localization of many transporters (3, 23, 24, 37 ). These cells are capable of direct and indirect protein targeting to both the basolateral and the apical membrane (32, 34) . The present work describes the construction of two fusion proteins, SPNT-GFP and CNT1-GFP, and their stable transfection into MDCK cells. We demonstrated that the GFP tag does not alter the substrate selectivity or functional localization of these transporters and only modestly affects kinetic characteristics of the tagged transporters compared with untagged transporters. Confocal imaging and functional studies indicated that both tagged transporters are primarily localized to the apical membrane in MDCK and LLC-PK 1 cells, although SPNT-GFP appears to have low levels of basolateral localization as well. This may be a result of saturation of pathway of membrane traffic to the apical membrane, as has been described previously for other n , where V is uptake of [ proteins (22) . It may also reflect a dual role for SPNT on both membranes. By stably expressing fluorescentlabeled SPNT and CNT1 in these cells, we have determined their subcellular localization ( Fig. 1) and provided a model for addressing further questions regarding the cellular role of these transporters. Renal clearance studies of nucleosides in humans indicate that adenosine is actively reabsorbed whereas deoxyadenosine and other nucleoside analog drugs (deoxyfluorouridine, zidovudine, and zalcitabine) are actively secreted (14, 15, 29) . Secretory flux of deoxyadenosine as well as several other nucleoside analog drugs has been linked to xenobiotic transporters including organic cation and organic anion transporters (1, 25, 26) . Our observation that SPNT and CNT1 predominantly localize to the apical membrane is consistent with studies in isolated renal apical membrane vesicles and suggests that these transporters play a role in the reabsorption of adenosine and other nucleosides rather than in the secretion of deoxyadenosine and nucleoside analog drugs.
These findings also implicate CNT1 and, in particular, SPNT in the adenosine pathway of renal autoregulation by placing them in proximity to the A 1 receptor. Northern blot analysis indicates that A 1 is the most abundant adenosine receptor type in the kidney (41) . Functional studies in the presence of adenosine receptor agonists and antagonists indicate that A 1 -type activity stimulates a majority of the known renal adenosine effects, including GFR and renin release (20, 21) . In addition, A 1 -receptor antagonists have been shown in animal studies to limit severity of acute renal failure (36) . Nucleoside transporters may serve to terminate adenosine receptor signaling by decreasing local concentrations of extracellular adenosine (13) . Interestingly, stable transfection of the A 1 receptor in MDCK cells demonstrates that ϳ80% of this receptor localizes to the apical membrane with the remaining 20% appearing on the basolateral membrane, similar to the results found for SPNT (33) . Although CNT1 is observed mainly in tissue where nucleoside salvage would be expected, SPNT has a much wider tissue distribution and is in high abundance within the heart, an organ with a large degree of adenosine receptor activity (7) . Thus SPNT may serve the additional function of modulating A 1 receptor-mediated effects of adenosine in the renal tubule and elsewhere by internalizing adenosine as well as inosine, its deaminated metabolite.
In summary, the localization of SPNT-GFP and CNT1-GFP to the apical membrane of MDCK and LLC-PK 1 cells supports the model of renal nucleoside reabsorption and suggests a role for these transporters in the modification of adenosine signaling at the A 1 receptor. In addition, the stably transfected cells provide a model for visualization of SPNT and CNT1 that may be used in the tracking of individual nucleoside transporters within mammalian cells. Localization under normal physiological conditions provides a starting point from which to begin exploring the trafficking pathways and regulatory responses of concentrative nucleoside transporters. For the first time, we are capable of observing the mobility of these transporters in response to physiological factors.
